美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Global X HealthTech ETF

29.50

+0.05430.18%

盤後：29.530.0256+0.09%16:15 EDT

成交量：1.66萬

成交額：48.95萬

市值：3,097.49萬

市盈率：- -

高：29.53

開：29.42

低：29.34

收：29.45

52周最高：33.59

52周最低：23.00

股本：104.98萬

流通股本：104.98萬

量比：1.82

換手率：1.58%

股息：0.07

股息率：0.24%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

春雨醫療午前升逾5% 明確AI驅動的數字醫療新賽道

期權聚焦 | TEM遠期虛值Call遭大額賣出、虛值Put獲買入，大單情緒集中偏空，上方空間受限？

Tempus AI Inc(TEM)股票8月24日盤中下跌7.10%：真相來了

TradingKey中文

Tempus AI獲FDA批准，其AI產品可通過標準心電圖識別肺動脈高壓跡象

市場消息： HIMS 的減重方案因信用卡糾紛遭到處罰。

Tempus AI Inc(TEM)股票8月21日盤中上漲8.36%：投資者必看的核心信息

TradingKey中文

Tempus AI Inc(TEM)股票8月20日盤中上漲10.87%：真相來了

TradingKey中文

巴克萊預計Hims銷售額將實現增長，但短期內面臨盈利壓力

春雨醫療盤中升逾8% 春雨醫生數字醫療服務能力已開始向線下場景延伸

Oscar Health Inc(OSCR)股票8月14日盤中上漲7.22%：背後推手曝光

TradingKey中文

隨着Hims準備推出肽類產品，華爾街對其今年的前景持謹慎態度

美國股市-受美伊僵局推高油價影響，華爾街期貨走勢平淡

美國研究綜述-Accendra Health、Celestica、Sionna Therapeutics

Hims & Hers Health預計毛利率將持續低於歷史水平，因國際及減肥業務擴張——電話會議透露

Hims & Hers Health提前測試肽類成分，靜待FDA關於允許藥物配製的決定——電話會議透露

Hims & Hers Health：CFO稱國際業務與減肥產品拖累Q2利潤率

Hims & Hers Health CFO：若現行法規允許，有信心快速擴大肽類產品規模

「Hims and Hers」股價上漲，因上調業績預期且季度營收增長

Hims & Hers Health Inc.：預計AI投資將在12至18個月內實現自我回報，並有望讓產品對客户更實惠

Hims & Hers Health：預計其國內業務將在下半年持續加速增長

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/HEAL/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":29.5043,"timestamp":1789761600000,"preClose":29.45,"halted":0,"volume":16594,"hourTrading":{"tag":"盘后","latestPrice":29.5299,"preClose":29.5043,"latestTime":"16:15 EDT","volume":18,"amount":530.7001,"timestamp":1789762500373,"change":0.0256,"changeRate":0.000868,"amplitude":0},"delay":0,"changeRate":0.0018438030560272104,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"休市中","change":0.0543,"latestTime":"09-18 16:00:00 EDT","open":29.42,"high":29.53,"low":29.3414,"amount":489509,"amplitude":0.006404,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":29.45,"sharesOutstanding":1329868,"nav":29.44,"aum":30913210.77,"dividendRate":0.002396,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":30.03,"preClose":29.45,"latestTime":"08:34 EDT","volume":24,"amount":720.72,"timestamp":1789734875443,"change":0.58,"changeRate":0.019694,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":29.5299,"preClose":29.5043,"latestTime":"16:15 EDT","volume":18,"amount":530.7001,"timestamp":1789762500373,"change":0.0256,"changeRate":0.000868,"amplitude":0},"volumeRatio":1.8210750722285791,"impliedVol":0.1809,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.8210750722285791,"shares":1049843,"dividePrice":0.0707,"high":29.53,"amplitude":0.006404,"preClose":29.45,"low":29.3414,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":29.5043,"eps":0,"divideRate":0.002396,"volume":16594,"delay":0,"ttmEps":0,"open":29.42,"prevYearClose":29.215,"prevWeekClose":28.39,"prevMonthClose":29.6135,"prevQuarterClose":27.59,"fiveDayClose":28.39,"twentyDayClose":30.1503,"sixtyDayClose":26.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662649997","title":"春雨醫療午前升逾5% 明確AI驅動的數字醫療新賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2662649997","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662649997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:59","pubTimestamp":1787716740,"startTime":"0","endTime":"0","summary":"上月，上市公司“国锐生活”正式更名为“春雨医疗”，标志着国锐生活全面转型AI驱动的全生命周期健康服务平台。半年时间，以传统物业和资产管理为主业的国锐生活，完成了一次跨界收购，将一家拥有70万+医生、近2亿用户的互联网医疗平台收入囊中，更将自身重新定义为一家医疗科技公司，明确了向AI驱动的数字医疗服务平台转型的战略方向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-26/doc-iniprivu5446355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMED","LGHT","GINN","FWD","AGIX","00108","CHAT","HTEC","AIPO","FDIF","BK1258","ARTY","QTOC","BK1229","GDOC","VTHR","HEAL","FDHT","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103520056","title":"期權聚焦 | TEM遠期虛值Call遭大額賣出、虛值Put獲買入，大單情緒集中偏空，上方空間受限？","url":"https://stock-news.laohu8.com/highlight/detail?id=1103520056","media":"期权女巫","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103520056?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 09:03","pubTimestamp":1787706189,"startTime":"0","endTime":"0","summary":"TEM收报68.73美元，涨幅3.87%。当日期权大单呈现集中偏空格局，一笔106.20万美元的远期虚值Call遭卖出，同时有16.10万美元的虚值Put获买入，显示资金对上方空间持谨慎态度，并提前布局下行风险。从全量大单情绪来看，TEM当日大单资金呈现明确偏空格局，且看多一侧几乎没有有效承接。资金主要集中在虚值Call卖出与虚值Put买入这两类典型偏空操作上，显示市场对后续股价表现缺乏乐观预期，更倾向于认为上方空间受限、并对未来回撤风险保持警惕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","TEM","BK4613","ARKG","BK4611","BK4121","LU1861559042.SGD","LU1861558580.USD","TEMT","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203379","title":"Tempus AI Inc(TEM)股票8月24日盤中下跌7.10%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203379","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203379?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 01:16","pubTimestamp":1787591778,"startTime":"0","endTime":"0","summary":"• 尽管获得 FDA 批准，Tempus AI 股价仍因获利了结而下跌。\n• 技术面超买与内部人士减持加剧了股价回调。\n• 该公司报告年营收为 12.7 亿美元，净亏损 2.4503 亿美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262128339-market-movers-tem-20260824","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4611","BK4121","TEM","TEMC","ARKG","BK4613","LU1861558580.USD","HEAL","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111988817","title":"Tempus AI獲FDA批准，其AI產品可通過標準心電圖識別肺動脈高壓跡象","url":"https://stock-news.laohu8.com/highlight/detail?id=1111988817","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111988817?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:31","pubTimestamp":1787574700,"startTime":"0","endTime":"0","summary":"Tempus AI（纳斯达克代码：TEM）近日宣布，其研发的AI产品已获得美国食品药品监督管理局（FDA）的批准。这款创新工具旨在利用标准心电图数据，辅助检测肺动脉高压的早期迹象。\n据悉，该AI系统通过分析常规心电图信号，能够捕捉到与肺动脉高压相关的细微异常，为临床医生提供更为精准的筛查依据。这一突破性进展，有望显著提升该疾病的诊断效率，尤其是在疾病早期阶段，从而为患者争取宝贵的治疗窗口。\nTempus AI表示，此次监管许可标志着公司在将人工智能技术深度融入心血管疾病诊断领域迈出了坚实一步。公司未来计划继续拓展AI在医疗健康领域的应用边界，推动更多智能化解决方案落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","TEM","HEAL","LU1861559042.SGD","LU1861558580.USD","BK4613","TEMT","ARKG","BK4611","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290875","title":"市場消息： HIMS 的減重方案因信用卡糾紛遭到處罰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290875?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 04:49","pubTimestamp":1787345385,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4196","HIMY","HIMC","THNR","HEAL","HIYY","GLAM","HIMZ","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924072","title":"Tempus AI Inc(TEM)股票8月21日盤中上漲8.36%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924072","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924072?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 02:16","pubTimestamp":1787336199,"startTime":"0","endTime":"0","summary":"• 受分析师上调评级及精准肿瘤学业务拓展推动，Tempus AI 股价上涨。\n• 第二季度业绩显示毛利率有所提升，且净利润录得正值。\n• 技术指标显示买入信号，但也伴随着超买迹象。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262125174-market-movers-tem-20260821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","TEM","HEAL","LU1861559042.SGD","LU1861558580.USD","BK4613","TEMT","ARKG","BK4611","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661885236","title":"Tempus AI Inc(TEM)股票8月20日盤中上漲10.87%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2661885236","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661885236?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 00:16","pubTimestamp":1787242573,"startTime":"0","endTime":"0","summary":"• 默克与莫德纳公布了个体化mRNA癌症疫苗积极的3期临床试验结果。\n• BTIG Research重申对Tempus AI的“买入”评级，并上调其目标价。\n• Tempus AI公布强劲的营收增长与毛利率表现，并上调了全年业绩指引。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262121731-market-movers-tem-20260820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4613","BK4611","LU1861558580.USD","TEMT","BK4121","LU1861559042.SGD","TEM","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287705","title":"巴克萊預計Hims銷售額將實現增長，但短期內面臨盈利壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287705","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287705?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 21:43","pubTimestamp":1787233415,"startTime":"0","endTime":"0","summary":"BUZZ-巴克莱预计Hims销售额将实现增长，但短期内面临盈利压力8月20日-** 远程医疗公司 Hims & Hers Health（HIMS.N）的股价在早盘交易中上涨 4%，至 32.35 美元** 巴克莱表示，预计HIMS的营收将实现增长，这主要得益于收购以及新业务领域的强劲增长** 但该行认为，“为支持增长而进行的投资将带来一定利润率压力”，这可能对近期盈利能力构成拖累** 该券商将该股","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4T44H12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","GLAM","BK4196","HIMY","HIMZ","HMYY","HEAL","THNR","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660109165","title":"春雨醫療盤中升逾8% 春雨醫生數字醫療服務能力已開始向線下場景延伸","url":"https://stock-news.laohu8.com/highlight/detail?id=2660109165","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660109165?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 10:23","pubTimestamp":1786933380,"startTime":"0","endTime":"0","summary":"模拟交易客户端春雨医疗盘中涨超8%，截至发稿，股价上涨3.44%，现报1.955港元，成交额92.680万港元。国锐生活近日发布公告，公司中文名称由“国锐生活有限公司”变更为“春雨医疗科技有限公司”。随着“春雨医疗科技”的正式启航，国锐集团将深度协同下属产业科技板块及资产管理板块，将春雨医生的数字医疗服务能力向更广泛的物业、社区及城市延伸。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-17/doc-ininqtnt7088779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FDHT","BK1258","FDIF","BK1229","GINN","BMED","GDOC","00108","HTEC","IEIH","HEAL","LGHT","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659125402","title":"Oscar Health Inc(OSCR)股票8月14日盤中上漲7.22%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2659125402","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659125402?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 01:16","pubTimestamp":1786727784,"startTime":"0","endTime":"0","summary":"• 在强劲的第二季度财报公布后，Oscar Health 上调了全年利润预期。\n• 营收与调整后每股收益大幅超出华尔街一致预期。\n• 随着公司费用率创下历史新低，运营效率进一步提升。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262108902-market-movers-oscr-20260814","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSCG","BK4162","OSCR","OSCX","BK4551","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902383","title":"隨着Hims準備推出肽類產品，華爾街對其今年的前景持謹慎態度","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902383","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902383?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 02:32","pubTimestamp":1786559535,"startTime":"0","endTime":"0","summary":"随着Hims准备推出肽类产品，华尔街对其今年的前景持谨慎态度Hims计划在年底前销售可合法生产的肽类产品分析师称，灰色市场上的肽类销售使得NAD+的需求难以量化一家配制药企的首席执行官表示，执法部门的酌情权可能允许更早地进行中期上市Amina Niasse路透纽约8月12日-Hims & Hers Health 计划于 2026 年推出部分合法可用的肽类产品，但本周这家远程医疗公司公布季度财报后，接受路透采访的投资者和分析师表示，该产品线的销售不太可能推动今年的营收增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4491HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","BK4196","HIMY","HMYY","HIMZ","HIYY","HIMS","THNR","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658686991","title":"美國股市-受美伊僵局推高油價影響，華爾街期貨走勢平淡","url":"https://stock-news.laohu8.com/highlight/detail?id=2658686991","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658686991?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 18:23","pubTimestamp":1786443814,"startTime":"0","endTime":"0","summary":"美国股市-受美伊僵局推高油价影响，华尔街期货走势平淡如需查看路透关于美国、英国和欧洲股市的实时博客，请点击LIVE/或在新闻窗口中输入LIVE/。期货：道指下跌0.09%，标普500指数上涨0.02%，纳斯达克指数上涨0.11%路透8月11日-周二，美国股指期货走势平淡，因美伊谈判陷入僵局推高了油价，令投资者在通胀前景仍不明朗的情况下不愿冒险。运动服饰品牌OnONON.N在美上市股价下跌16.2%，此前该公司第二季度净销售额未达  华尔街预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T4480NA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD2.UK","QQQA","XLK","SMHX","METV","XNTK","THMR","ABFL","HIMZ","RKLB","TEK","SOXQ","HMYY","HIYY","HIMS","SNVD.UK","AGOX","JGRO","CLSE","NVD3.UK","BKCH","AIFD","DRIV","GLAM","RKLX","THNR","ARTY","CNEQ","HIMY","FDTX","RKLZ","SOXX","AIQ","AIPI","INTC","NVDA","FAI","RIOT","TRFK","RIOX","VGT","CMAG","BLOX","NVDS.UK","DAPP","HEAL","SMH","INTW","TYLG","WISE"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658998788","title":"美國研究綜述-Accendra Health、Celestica、Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998788","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998788?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 16:11","pubTimestamp":1786435905,"startTime":"0","endTime":"0","summary":"美国研究综述-Accendra Health、Celestica、Sionna Therapeutics路透8月11日-周二，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括Accendra Health、Celestica和Sionna Therapeutics。股票条目按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S4480H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLBK","ROOT","TEK","CLS","PRU","EBAY","BBIO","PBE","MKTX","EQH","LIF","NABL","ORKA","AFL","LYFT","TENX","WBTN","KLAC","DASH","DKNG","EXPE","AFG","SHOC","INTU","SION","VNQ","AIOT","RGA","RPD","THNR","SYRE","SCHH","LRCX","HEAL","RCKT","SKWD","PRI","EPAI","VRTX","ETSY","HIMS","PUBM","AMAT","ACH","CEVA","SPG","MET","MO","DKUP","IETC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103305801","title":"Hims & Hers Health預計毛利率將持續低於歷史水平，因國際及減肥業務擴張——電話會議透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103305801","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103305801?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 05:34","pubTimestamp":1786397692,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.在电话会议中透露，由于国际市场的拓展以及减肥业务的扩张，公司预计毛利率将长期维持在历史低位以下。这一趋势打破了以往相对稳定的盈利水平，反映出公司在全球化和新产品线布局上的大胆投入。尽管此举可能短期内压缩利润空间，但高层认为，这是实现长期增长的关键一步。随着业务版图不断延伸，毛利率的波动性或将加剧，从而考验投资者的耐心与信心。然而，管理层强调，这些战略调整旨在捕捉更广阔的市场机遇，而非简单的财务妥协。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","THNR","HIMZ","HEAL","HMYY","BK4196","HIYY","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124573842","title":"Hims & Hers Health提前測試肽類成分，靜待FDA關於允許藥物配製的決定——電話會議透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124573842","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124573842?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 05:20","pubTimestamp":1786396838,"startTime":"0","endTime":"0","summary":"在即将到来的FDA关键决策之前，Hims & Hers Health Inc.已悄然展开肽类成分的测试工作。这家健康科技公司正密切关注监管机构是否允许针对这些药物进行配制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMY","BK4196","HIMZ","HMYY","HIYY","HIMS","GLAM","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168471363","title":"Hims & Hers Health：CFO稱國際業務與減肥產品拖累Q2利潤率","url":"https://stock-news.laohu8.com/highlight/detail?id=1168471363","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168471363?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:56","pubTimestamp":1786395415,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 首席财务官坦言，国际业务拓展以及减肥产品的销售，在第二季度拉低了公司的整体利润率。这些领域的运营特征，与核心业务相比，呈现出不同的盈利表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","HMYY","HEAL","GLAM","HIYY","BK4196","THNR","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192063839","title":"Hims & Hers Health CFO：若現行法規允許，有信心快速擴大肽類產品規模","url":"https://stock-news.laohu8.com/highlight/detail?id=1192063839","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192063839?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:44","pubTimestamp":1786394681,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 首席财务官表示，公司对在现行法规允许的情况下快速扩大其肽类产品供应规模充满信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","THNR","GLAM","HIYY","HEAL","HMYY","BK4196","HIMZ","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658590369","title":"「Hims and Hers」股價上漲，因上調業績預期且季度營收增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2658590369","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658590369?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:21","pubTimestamp":1786393262,"startTime":"0","endTime":"0","summary":"BUZZ-“Hims and Hers”股价上涨，因上调业绩预期且季度营收增长8月10日-** 远程医疗公司 Hims & Hers（HIMS.N）的股价在盘后交易中上涨 3%，报 33 美元**得益于订阅用户数量增长及个性化医疗服务范围的扩大，HIMS公布第二季度营收增长(link)，并上调全年业绩预期** 据伦敦证券交易所集团（LSEG）汇编的数据，该公司第二季度营收为7.53亿美元，而去年同期为5.44亿美元；分析师此前预计营收为6.9989亿美元**将2026财年营收预期从之前的28亿至30亿美元区间上调至31亿至33亿美元** 计入当日交易波动，该股年初至今累计下跌2.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4471FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMY","HEAL","HIYY","THNR","GLAM","BK4196","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137770526","title":"Hims & Hers Health Inc.：預計AI投資將在12至18個月內實現自我回報，並有望讓產品對客户更實惠","url":"https://stock-news.laohu8.com/highlight/detail?id=1137770526","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137770526?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:11","pubTimestamp":1786392685,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 预计其在人工智能领域的投资，将在12至18个月内实现自我回报。公司还预期，这些投入将有助于使其产品和服务对客户而言更加亲民、更具性价比。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMY","HEAL","THNR","HIMS","HIMZ","BK4196","GLAM","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169345584","title":"Hims & Hers Health：預計其國內業務將在下半年持續加速增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1169345584","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169345584?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392543,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 表示，预计其国内业务将在今年下半年继续加速扩张。这一乐观展望，凸显了公司对自身增长轨迹的坚定信心。随着市场对其健康解决方案的需求持续攀升，该企业正积极准备迎接新一轮业绩高峰。从当前态势看，其国内业务不仅有望维持强劲势头，更可能进一步突破预期，为整体财务表现注入源源不断的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMY","THNR","HEAL","HIYY","GLAM","HIMZ","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":93,"code":"91000000","status":"200"}]}}